Janneke Wilschut MSc

Dr. Janneke Wilschut is a researcher at the section Innovation and Public Sector Efficiency within the faculty of Technology, Policy and Management of Delft University of Technology. Recently, she finished her PhD thesis at the department of Public Health at ErasmusMC. During her PhD she studied the cost-effectiveness of screening for colorectal cancer. Before that, she worked at TNO Innovation for life where she applied her econometrical knowledge on militairy operations.

Fecal occult blood testing when colonoscopy capacity is limited.

Wilschut JA, Habbema JDF, van Leerdam ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ, van Ballegooijen M.

Journal of the National Cancer Institute, accepted for publication.

Cost-Effectiveness Analysis of a Quantitative Immunochemical Test for Colorectal Cancer Screening.

 Wilschut JA, Hol L, Dekker E, Jansen JB, van Leerdam ME, Lansdorp-Vogelaar I, Kuipers EJ, Habbema JD, van Ballegooijen M.

Gastroenterology, accepted for publication.

Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial.

 van Roon AH, Hol L, Wilschut JA, Reijerink JC, van Vuuren AJ, van Ballegooijen M, Habbema JD, van Leerdam ME, Kuipers EJ

Preventive Medicine. 2011 Jun 1;52(6):448-51.

Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance.

Van Roon AHC, Wilschut JA, Hol L,van Ballegooijen M, Reijerink JCIY.,’t Mannetje H, Kranenburg LJC, Biermann K, van Vuuren AJ, Francke J,van der Togt ACM, Habbema JDF,van Leerdam ME,Kuipers EJ.

Clinical Gastroenterology and Hepatology 2011;9:333–339.

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?

 Wilschut JA, Steyerberg EW, van Leerdam ME, Lansdorp-Vogelaar I, Habbema JD, van Ballegooijen M.

Cancer. 2011 Mar 8. doi: 10.1002/cncr.26009.

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis.

 Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M.

Cancer Causes and Control. 2010 Dec;21(12):2287-93.

Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, Wilschut JA, Zauber AG, van Ballegooijen M.

Annals of Internal Medicine. 2010 Sep 21;153(6):368-77.

A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.  

Ramsey SD, Wilschut J, Boer R, van Ballegooijen M.

American Journal of Gastroenterology. 2010 Aug;105(8):1861-9.

Individualizing colonoscopy screening by sex and race.

 Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JD.

Gastrointestinal Endoscopy. 2009 Jul;70(1):96-108,

Screening  for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.  

Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME.

British Journal of Cancer. 2009 Apr 7;100(7):1103-10.

At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.

 Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD.

International Journal of Cancer. 2009 Mar 1;124(5):1161-8.

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

 Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

Annals of Internal Medicine. 2008 Nov 4;149(9):659-69.

Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET) [Internet].

Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Mar.

Available from www.ncbi.nlm.nih.gov/bookshelf/br.fcgi